City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Kimlin Ashing-Giwa, PhD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 15160 ClinicalTrials.gov Number: NCT02513407

Principal Investigator: Kimlin Ashing-Giwa, PhD
Sponsor: Institutional

Title:  Reducing Cancer and Chronic Disease Risk in Medically Vulnerable Communities: A Feasibility Study Measuring Behavioral and Biological Outcomes of the Eat, Move, Live Intervention

COH Protocol Number: 12383 ClinicalTrials.gov Number: NCT01824745

Principal Investigator: Kimlin Ashing-Giwa, PhD
Sponsor: Institutional

Title:  Survivorship Care Planning for At Risk Breast Cancer Survivors: A Focus on Latina-, Asian-, African-, and European Americans

COH Protocol Number: 12182

Principal Investigator: Kimlin Ashing-Giwa, PhD
Sponsor: Institutional

Title:  Impact of Cancer, Community Cancer-Related Needs, and Knowledge and Acceptability of Research Participation

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.